Mrinal M. Gounder, MD

Associate Attending Physician
Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center

I am a medical oncologist specializing in treating bone and soft tissue sarcoma. I specialize in clinical trials of early to late-stage (phase I, II, III) drugs across all solid tumors including sarcoma. I practice at Memorial Sloan Kettering Cancer center in New York and have over 10 years of experience in drug development and clinical trials.

Poster(s):

• (P 134) PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA

• (P 163) PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MURINE DOUBLE MINUTE 2–TUMOR PROTEIN 53 ANTAGONIST BI 907828 IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED SOLID TUMORS

• (P 268) INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)